Leerink Partners analyst Michael Cherny has reiterated their neutral stance on DGX stock, giving a Hold rating yesterday. Michael Cherny has ...
Oct 23 - Lab operator Quest Diagnostics (DGX.N), opens new tab said on Wednesday it will launch a test for H5N1 bird flu at ...
Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.
Good thing I’m not their boss. They would be gone. I have used Quest Diagnostics for over two years. My results are important to me due to the fact that I have a kidney transplant. It is very ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
(RTTNews) - Quest Diagnostics (DGX) announced Monday that it has completed its previously announced acquisition of select laboratory assets from OhioHealth, a nationally recognized not-for-profit ...
It's been a good week for Quest Diagnostics Incorporated ( NYSE:DGX ) shareholders, because the company has just... DXCM's third-quarter 2024 earnings and revenues surpass expectations ...
Quest Diagnostics is a dominant player in the growing medical testing industry, offering consistent earnings and dividend growth with lower volatility. DGX benefits from secular tailwinds like ...
Black Friday Meta Quest deals may arrive at the end of this month, but the first few deals are already starting to trickle through. Of course, discounts on the headsets are unlikely to come early ...
The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Please note that the dividend history for Nasdaq stocks ...
A diagnostic is a test (often using a device) used to assist in the diagnosis of a disease, predict the likelihood of a disease developing or progressing, or predict the likelihood of a response ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...